http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220085726-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d242c6c229c7edae9f03a32bba7f1ea |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate | 2021-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eb1464b071c8544b682535f709837be |
| publicationDate | 2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20220085726-A |
| titleOfInvention | Novel peptide of inhibiting bet protein and composition for preventing and treating ophthalmic diseases comprising the same |
| abstract | The present invention relates to a pharmaceutical composition for the prevention or treatment of various eye diseases, such as glaucoma, uveitis, wet and dry macular degeneration, and age-related macular degeneration, containing the novel peptide and the composition as an active ingredient, and the novel peptide according to the present invention was confirmed to exhibit the effect of preventing and improving various eye diseases caused by retinal degeneration by inhibiting BET protein to improve inflammation caused by retinal damage caused by epigenetic changes , uveitis, wet and dry macular degeneration, age-related macular degeneration, etc. can be provided as a pharmaceutical composition for the prevention or treatment of various eye diseases. |
| priorityDate | 2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.